Reference |
Disease |
---|---|
MLP1108 | Ehlers-Danlos syndrome |
SEQ1105 | Phakomatosis |
PRE7004 | Tuberous sclerosis |
SEQ1092 | Phakomatosis |
SEQ1101 | Hermansky-Pudlak syndrome |
SEQ9651 | Waardenburg syndrome, syndrome |
SEQ9661 | Werner syndrome |
SEQ9301 | Polymorphic catecholaminergic ventricular tachycardia (CPVT) |
SEQ8492 | Pterygium Syndrome (Lethal Forms) |
SEQ8493 | Pterygium Syndrome (Lethal Forms) |
SEQ8471 | Elastic Pseudoxanthoma |
SEQ8481 | Pustular psoriasis 14 |
SEQ8491 | Pterygium Syndrome (Lethal Forms) |
SEQ8401 | Proteus syndrome |
SEQ8411 | Erythropoietic protoporphyria |
SEQ8412 | Erythropoietic protoporphyria |
SEQ8421 | Prune Belly Syndrome |
SEQ8351 | Cutaneous Porphyria tardive |
SEQ8361 | Congenital erythropoietic porphyria |
SEQ8371 | Porphyria variegata |
SEQ8335 | Polyarteritis nodosa / Sneddon syndrome |
SEQ8291 | Pycnodysostosis |
SEQ8311 | Piebaldism |
SEQ8181 | Parkes Weber syndrome |
SEQ8101 | Papillon-Lefevre syndrome |
SEQ7851 | Oto-palato-digital syndrome type 2 |
SEQ7762 | Omenn syndrome |
SEQ7763 | Omenn syndrome |
SEQ7764 | Omenn syndrome |
SEQ7511 | Nijmegen syndrome |
SEQ7512 | Nijmegen syndrome |
SEQ7421 | Neurofibromatosis-like syndromes |
SEQ7423 | Neurofibromatosis type 2 |
SEQ7401 | Nail Patella Syndrome |
SEQ7211 | Mowat-Wilson syndrome |
SEQ7105 | Marshall-Smith syndrome |
SEQ7121 | MENKES syndrome |
SEQ6932 | Generalized Congenital Lipodystrophy (Berardinelli-Seip) type 1 |
SEQ6933 | Generalized Congenital Lipodystrophy (Berardinelli-Seip) type 2 |
SEQ6934 | Generalized Congenital Lipodystrophy (Berardinelli-Seip) type 3 |
SEQ6935 | Generalized Congenital Lipodystrophy (Berardinelli-Seip) type 4 |
SEQ6936 | Acquired partial lipodystrophy (Barraquer-Simons syndrome) |
SEQ6841 | Leopard syndrome |
SEQ6842 | sg Leopard syndrome |
SEQ6831 | Legius syndrome (Neurofibromatosis Type 1-like) |
SEQ6178 | Ichthyosis vulgaris with autosomal dominant transmission |
SEQ6167 | Autosomal Recessive Congenital Ichthyosis |
SEQ6169 | Lamellar ichthyosis |
SEQ6174 | Harlequin fetus congenital ichthyosis |
SEQ6175 | Superficial epidermolytic ichthyosis |
SEQ6176 | X-linked ichthyosis |
SEQ6177 | Ichthyosis vulgaris with autosomal dominant transmission |
SEQ6161 | Autosomal Recessive Congenital Ichthyosis |
SEQ6162 | Autosomal Recessive Congenital Ichthyosis |
SEQ6163 | Autosomal Recessive Congenital Ichthyosis |
SEQ6164 | Autosomal Recessive Congenital Ichthyosis |
SEQ6165 | Autosomal Recessive Congenital Ichthyosis |
SEQ6166 | Autosomal Recessive Congenital Ichthyosis |
SEQ6131 | Homocystinuria due to cystathionine beta-synthase deficiency |
SEQ6132 | Homocystinuria due to cystathionine beta-synthase deficiency |
SEQ6151 | Hutchinson-Gilford Progeria |
SEQ6095 | Focal dermal hypoplasia |
SEQ6061 | Benign familial hypobetalipoproteinemia |
SEQ6045 | Hyperhomocysteinemia |
SEQ6029 | Hyperhomocysteinemia |
SEQ5982 | Hyper IgE |
SEQ5981 | Hydroletal Syndrome |
SEQ5926 | Hermansky-Pudlak syndrome |
SEQ5927 | Hermansky-Pudlak syndrome |
SEQ5928 | Hermansky-Pudlak syndrome |
SEQ5929 | Hermansky-Pudlak syndrome |
SEQ5930 | Hermansky-Pudlak syndrome |
SEQ5919 | Neonatal Hemangioma |
SEQ5921 | Hermansky-Pudlak syndrome type 2 |
SEQ5922 | Hermansky-Pudlak syndrome |
SEQ5924 | Hermansky-Pudlak syndrome |
SEQ5925 | Hermansky-Pudlak syndrome |
SEQ5751 | Griscelli syndrome type 1 |
SEQ5741 | Gorlin syndrome |
SEQ5742 | Gorlin syndrome |
SEQ5671 | GAPO syndrome |
SEQ5610 | Phytosterolemia |
SEQ5651 | Galactosialidosis |
SEQ5571 | Juvenile hyaline fibromatosis |
SEQ5501 | Fabry disease |
SEQ5265 | Tuberous sclerosis |
SEQ5266 | Tuberous sclerosis |
SEQ5267 | Tuberous sclerosis |
SEQ5212 | Primary erythermalgia |
SEQ5213 | Primary erythermalgia |
SEQ5231 | Bullous ichthyosiform congenital erythroderma |
SEQ5232 | Bullous ichthyosiform congenital erythroderma |
SEQ5241 | Variable erythrokeratoderma, Mendes da Costa type |
SEQ5211 | Primary erythermalgia |
SEQ5111 | Junctional Epidermolysis Bullosa with Pyloric Atresia |
SEQ5112 | Simple Epidermolysis Bullosa |
SEQ5121 | Simple Epidermolysis Bullosa with Muscular Dystrophy |
SEQ5093 | Dystrophic Epidermolysis Bullosa |
SEQ5103 | Junctional Epidermolysis Bullosa |
SEQ5104 | Junctional Epidermolysis Bullosa |
SEQ5105 | Junctional Epidermolysis Bullosa |
SEQ5106 | Junctional Epidermolysis Bullosa |
SEQ5082 | Epidermodysplasia verruciformis |
SEQ5083 | Epidermodysplasia verruciformis |
SEQ4871 | Ehlers-Danlos type VIIC |
SEQ4872 | Ehlers-Danlos syndrome Musculocontractural type |
SEQ4866 | Ehlers-Danlos Syndrome Type III |
SEQ4867 | Ehlers-Danlos Syndrome Type III |
SEQ4868 | Ehlers-Danlos Syndrome Type III |
SEQ4869 | Ehlers-Danlos Syndrome Type IV (vascular) |
SEQ4870 | Ehlers-Danlos syndrome type VI |
SEQ4851 | Ectrodactyly, Ectodermal Dysplasia and Palatal Cleft Syndrome type 3 (EEC Type 3) |
SEQ4861 | Ehlers-Danlos syndrome CLASSIC TYPE |
SEQ4862 | Ehlers-Danlos syndrome |
SEQ4863 | Ehlers-Danlos syndrome type I / type II (classic) |
SEQ4864 | Ehlers-Danlos syndrome type I / type II (classic) |
SEQ4865 | Ehlers-Danlos syndrome type I / type II (classic) |
SEQ4345 | Congenital dyskeratosis |
SEQ4346 | Congenital dyskeratosis |
SEQ4347 | Congenital dyskeratosis |
SEQ4348 | Congenital dyskeratosis |
SEQ4341 | Congenital dyskeratosis |
SEQ4342 | Congenital dyskeratosis |
SEQ4343 | Congenital dyskeratosis |
SEQ4344 | Congenital dyskeratosis |
SEQ4279 | X-linked Anhidrotic Ectodermal Dysplasia, Christ-Siemens-Touraine syndrome |
SEQ4271 | Ectodermal Dysplasia |
SEQ4272 | Ectodermal dysplasia - ectrodactyly - macular dystrophy (EEM syndrome) |
SEQ4273 | Ectodermal Dysplasia 2, Clouston type |
SEQ4275 | Autosomal Anhydrotic Ectodermal Dysplasia |
SEQ4276 | Autosomal Anhydrotic Ectodermal Dysplasia |
SEQ4277 | Anhidrotic Ectodermal Dysplasia with immune deficiency |
SEQ4012 | Desbuquois syndrome |
SEQ3561 | Interleukin 1 receptor antagonist deficiency |
SEQ3461 | Biotinidase deficiency |
SEQ3132 | Crouzon Syndrome with Acanthosis Nigricans |
SEQ3141 | Crouzon syndrome, syndrome |
SEQ3351 | Darier's disease |
SEQ3131 | Crouzon syndrome with Acanthosis Nigricans, mutation p.Ala391Glu FGFR3 gene |
SEQ3081 | Costello syndrome |
SEQ2921 | Cockayne syndrome |
SEQ2922 | Cockayne syndrome |
SEQ2923 | Cockayne syndrome |
SEQ2861 | Cinca Syndrome (Childhood Multisystemic Inflammatory Disease) |
SEQ2831 | Chediak-Higashi syndrome |
SEQ2681 | Canavan disease |
SEQ2691 | Cantú syndrome |
SEQ2431 | Bruck syndrome |
SEQ2601 | C syndrome |
SEQ2421 | BRESEK syndrome |
SEQ2381 | Branchial-oculo-facial syndrome |
SEQ2341 | Blau syndrome |
SEQ2311 | Síndrome de Birt-Hogg-Dube, mutaciones c.1285delC y c.1285dupC gen FLCN Birt-Hogg-Dube syndrome, c.1285delC and c.1285dupC mutations FLCN gene |
SEQ2312 | Birt-Hogg-Dube syndrome |
SEQ2241 | Bardet-Biedl syndrome type 1 |
SEQ2233 | Bardet-Biedl syndrome type 13 |
SEQ2027 | Autosomal dominant cutis laxa type 2B |
SEQ2028 | Autosomal dominant cutis laxa type 3A |
SEQ2021 | Autosomal dominant cutis laxa type 1 |
SEQ2022 | Autosomal dominant cutis laxa type 2 |
SEQ2024 | Autosomal dominant cutis laxa type 1B |
SEQ2025 | Autosomal dominant cutis laxa type 1C |
SEQ2026 | Autosomal dominant cutis laxa type 2A |
SEQ2015 | Familial autoinflammatory type Behcer-likem syndrome |
SEQ1831 | Pyogenic arthritis, pyoderma gangrenosum, acne |
SEQ1781 | Apert syndrome, p.Ser252Trp and p.Pro253Arg mutations by FGFR2 gene sequencing |
SEQ1711 | Hereditary Angioedema |
SEQ1712 | Hereditary Angioedema |
SEQ1471 | Alpha-Thalassemia |
SEQ1491 | Glycogen storage due to muscle phosphofructokinase deficiency |
SEQ1412 | Albinism isolated and syndromic forms |
SEQ1414 | Oculocutaneous albinism type 2 |
SEQ1392 | Hereditary angioedema |
SEQ1351 | Adams-Oliver syndrome |
SEQ1352 | Adams-Oliver syndrome |
SEQ1356 | Adams-Oliver syndrome |
SEQ1263 | Methylmalonic acidemia, vitamin B12 sensitive, type cbl B |
SEQ1059 | Neurofibromatosis |
MLP3431 | Tricho-rhino-phalangeal syndrome type 1 / Langer-Giedion syndrome |
MLP3550 | Waardenburg syndrome |
MLP3401 | Hereditary hemorrhagic telangiectasia, Primary pulmonary hypertension |
MLP3031 | Pseudoxanthoma elasticum |
MLP3021 | Porphyrias |
MLP2743 | Neurofibromatosis type 2 |
MLP2741 | Neurofibromatosis type 1 |
MLP2742 | Neurofibromatosis type 1 |
MLP2701 | Nail Patella syndrome |
MLP2561 | Menkes syndrome |
MLP2542 | Marfan syndrome |
MLP2205 | Mediterranean fever family |
MLP2151 | Hyper-IgE syndrome |
MLP2201 | X-linked ichthyosis |
MLP2001 | Gorlin syndrome |
MLP1831 | Tuberous sclerosis 1 |
MLP1832 | Tuberous sclerosis 2 |
MLP1870 | Fabry disease |
MLP1801 | Ehlers-Danlos type III syndrome |
MLP1802 | Ehlers Danlos type VI syndrome |
MLP1671 | Branchio-oto-renal dysplasia |
MLP1231 | Birt-Hogg-Dube syndrome |
MLP1031 | Oculocutaneous albinism type II |
EXN1167 | Lymphatic Malformations and Related Diseases |
EXN1162 | Epidermolysis Bullosa |
EXN1138 | Progeria and Progeroid syndromes |
EXN1127 | Waardenburg syndrome |
EXN1107 | Albinism |
EXN1110 | Hermansky‐Pudlak syndrome |
EXN1094 | Cutis laxa |
EXN1098 | Connective tissue diseases |
EXN1063 | Ectodermal dysplasias |
EXN1047 | Hyperimmunoglobulin E syndrome |
EXN1041 | Hereditary Hemorrhagic Telangiectasia |
EXN1031 | Joint hypermobility |
EXN1023 | Congenital ichthyosis |
EXN1017 | Trichohepatoenteric syndrome |
SEQ references correspond to studies performed using NIMSeq® | |
EXN references correspond to studies performed using ExoNIM® |
To consult the genes associated with each approach and the complete catalog of services, go to our genetics test search tool